Seres Therapeutics Inc (MCRB) Live Share Price, Invest From India

Seres Therapeutics Inc Stock Performance

as on March 31, 2026 at 6:59 am IST

Day's Low
Day's High
$8.46
Day's Price Range
$9.55
$8.90
4.94%
Downside
7.30%
Upside
52 Week's Low
52 Week's High
$6.53
52-Week Price Range
$29.98
$8.90
26.63%
Downside
236.85%
Upside

Seres Therapeutics Inc share price movements today

Previous Close: $9.00
Open: $8.99
Volume: 419.2K
Day's Low - High: $8.46 - $9.55
52 Week Low - High: $6.53 - $29.98

Seres Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: -40.86 %
1 Year Return: -37.15 %
3 Year Return: -92.24 %
5 Year Return: -97.86 %

Seres Therapeutics Inc Stock Fundamentals & Key Indicators

Check Seres Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$86.3M

EPS (TTM)

-8.23

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.92%

PE Ratio (TTM)

14.06

Industry PE ratio

-4.138478964401295

PEG Ratio

-0.11

EBITDA

-89.8M

Revenue (TTM)

789.0K

Profit Margin

721.93%

Return On Equity TTM

19.64%

Seres Therapeutics Inc Stock Valuation

Track how Seres Therapeutics Inc P/E has moved over time to understand its valuation trends.

Seres Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-163.63x)

March 31, 2022

Industry (-4.14x)

March 31, 2026

Today (14.06x)

March 31, 2026

Highest (-1.78x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 14.06x

Seres Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Seres Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Seres Therapeutics Inc	BUY	$86.3M	-97.86%	14.06	721.93%
Alnylam Pharmaceuticals, Inc.	BUY	$42.1B	123.88%	136.79	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$110.0B	106.23%	28.25	32.94%
Beone Medicines Ltd	NA	$32.5B	NA	115.05	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.0B	58.37%	17.79	31.41%

Stock Returns calculator for Seres Therapeutics Inc Stock including INR - Dollar returns

The Seres Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Seres Therapeutics Inc investment value today

Current value as on today

₹70,446

Returns

-₹29,554

(-29.55%)

Returns from Seres Therapeutics Inc Stock

-₹36,429 (-36.43%)

Dollar Impact

₹6,875 (+6.87%)

Analyst Recommendation on Seres Therapeutics Inc Stock

Based on 13 analysts

BUY

76.92%

Buy

15.38%

Hold

7.69%

Sell

Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Seres Therapeutics Inc. Average target price of $22

Seres Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Seres Therapeutics Inc.

What analysts predicted

59.55%UPSIDE

Target Price

$22

Current Price

$8.9

Analyzed by

13 Analysts

Target

$22.00

Seres Therapeutics Inc target price $22, a slight upside of 59.55% compared to current price of $8.9. According to 13 analysts rating.

Seres Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Seres Therapeutics Inc Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 1, 2026 to March 31, 2026

Change:-41% versus previous 30 day period

Seres Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	-	-	-	5	-	-	0	0
Gross Profit	-1	0	-1	-1	-1	2	-3	-1	-13	14
Operating Income	-44	-39	-34	-28	-29	-28	-27	-24	-22	-19
EBITDA	-39	-35	-30	-24	-49	-14	33	-18	9	-17
Interest Expense	4	4	4	3	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	0
Income Before Tax	-41	-41	-32	-26	-51	-15	32	-19	8	-15
Income Tax Expense	1	-2	1	0	-	-	-	-	-	-
Net Income	-47	-41	-40	-32	88	-15	32	-19	8	-15
Net Profit Margin	-15436.77%	-64450.00%	0.00%	0.00%	0.00%	-262.45%	0.00%	0.00%	2337.32%	-3501.14%

Seres Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	21	32	28	34	33	144	7	126	-	0
Gross Profit	-60	-57	28	34	-57	144	6	125	-3	-3
Operating Income	-92	-91	-100	-71	-88	-64	-179	-195	-121	-93
EBITDA	-88	-82	-92	-62	-77	-56	-170	-181	-120	-89
Interest Expense	0	1	1	0	2	2	6	13	-	-
Depreciation	-	7	7	7	6	5	6	6	5	4
Income Before Tax	-91	-89	-98	-70	-89	-65	-183	-190	-125	5
Income Tax Expense	2	-1	1	-6	-2	-4	3	14	0	-
Net Income	-91	-89	-98	-70	-89	-65	-250	-113	0	5
Net Profit Margin	-420.74%	-278.44%	-350.03%	-203.68%	-268.33%	-45.25%	-3509.50%	-90.02%	0.00%	721.93%

Seres Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-34	-40	-32	88	-15	32	-19	8	-15
Operating Cash Flow	-47	-35	-39	-34	-38	26	-13	2	-14
Investing Cash Flow	0	0	1	141	0	0	0	0	0
Financing Cash Flow	6	18	-	-110	1	1	-	0	12
Change in Cash	-41	-16	-38	-4	-37	28	-13	2	-1

Seres Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-89	-98	-70	-89	-65	-250	-113	0	5
Operating Cash Flow	-75	-62	-76	-93	6	-228	-117	-148	1
Investing Cash Flow	56	112	-30	-158	64	82	10	142	0
Financing Cash Flow	0	0	86	303	1	129	71	-90	13
Change in Cash	-18	49	-20	50	71	-16	-35	-96	14

Global Institutional Holdings in Seres Therapeutics Inc

Funds	Holdings
Marshall Wace Asset Management Ltd	1.26%
Marshall Wace Asset Management Ltd	1.39%
Lion Point Capital, LP	0.33%
State Street Corp	0.31%
Geode Capital Management, LLC	0.94%

See all

Insights on Seres Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, MCRB stock has moved up by 6.3%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 351.0K → 438.0K (in $), with an average increase of 19.9% per quarter
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 799.2% return, outperforming this stock by 891.4%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 101.0% return, outperforming this stock by 138.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 8.20M → -15.33M (in $), with an average decrease of 286.9% per quarter

About Seres Therapeutics Inc

seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.

Organisation	Seres Therapeutics Inc
Headquarters	101 Cambridgepark Drive, Cambridge, MA, United States, 02140
Industry	Health Technology
CEO	Mr. Richard N. Kender B.S., M.B.A.
E-voting on shares	Click here to vote

Key Management of Seres Therapeutics Inc

Name	Title
Ms. Marella Thorell CPA	Executive VP & CFO
Ms. Kelly Brady M.S.	Executive VP & COO
Mr. Chris McChalicher	Executive VP & CTO
Dr. Dennis M. Walling M.D.	Senior VP of Clinical Development & Head of Clinical Research
Ms. Ann Kurowski	Senior Vice President of Regulatory Affairs
Mr. Richard N. Kender B.S., M.B.A.	Interim CEO & Executive Chair
Mr. Thomas J. DesRosier Esq., J.D.	Executive VP & Chief Legal Officer
Dr. Matthew R. Henn Ph.D.	President & Chief Scientific Officer

FAQs

What is Seres Therapeutics Inc share price today?

Seres Therapeutics Inc share price today is $8.9 as on March 31, 2026 at 1:29 am IST at the close of the market. Seres Therapeutics Inc share today touched a day high of $9.55 and a low of $8.46.

What is the 52 week high and 52 week low for Seres Therapeutics Inc share?

Seres Therapeutics Inc share touched a 52 week high of $29.98 on November 20, 2025 and a 52 week low of $6.53 on May 15, 2025. Seres Therapeutics Inc stock price today i.e. March 31, 2026 at 1:29 am IST is closed at $8.9,which is 70.31% down from its 52 week high and 36.29% up from its 52 week low.

What is Seres Therapeutics Inc's market capitalisation today?

Seres Therapeutics Inc market capitalisation is $0.00T as on March 31, 2026 at 1:29 am IST.

How to invest in Seres Therapeutics Inc Stock (MCRB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Seres Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seres Therapeutics Inc Shares that will get you 0.1685 shares as per Seres Therapeutics Inc share price of $8.9 per share as on March 31, 2026 at 1:29 am IST.

What is the minimum amount required to buy Seres Therapeutics Inc Stock (MCRB) from India?

Indian investors can start investing in Seres Therapeutics Inc (MCRB) shares with as little as ₹94.702 or $1 (as of March 31, 2026 at 4:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹947.02 in Seres Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 31, 2026 at 4:40 pm IST). Based on Seres Therapeutics Inc share’s latest price of $8.9 as on March 31, 2026 at 1:29 am IST, you will get 1.1236 shares of Seres Therapeutics Inc. Learn more about fractional shares .

What are the returns that Seres Therapeutics Inc has given to Indian investors in the last 5 years?

Seres Therapeutics Inc stock has given -97.86% share price returns and 29.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?